Tenax Therapeutics Inc

NASDAQ:TENX  
1.09
-0.01 (-0.91%)
Earnings Announcements

Tenax Therapeutics Reports Third Quarter 2020 Results And Provides Business Update

Published: 11/16/2020 21:51 GMT
Tenax Therapeutics Inc (TENX) - Tenax Therapeutics Reports Third Quarter 2020 Results and Provides Business Update.
Q3 Loss per Share $0.18.
Tenax Therapeutics - Expects Current Cash, Cash Equivalents and Marketable Securities Will Be Sufficient to Fund Current Operations Through Q3 of 2021.
Cash, Cash Equivalents and Marketable Securities Totaled $8.7 Million As of September 30, 2020.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.13

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.